Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000790836 | SCV000227419 | pathogenic | not provided | 2013-08-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003502506 | SCV004295441 | pathogenic | ALG9 congenital disorder of glycosylation | 2023-08-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 845). This premature translational stop signal has been observed in individual(s) with cutis laxa (PMID: 18157129, 27896089, 31980526). This variant is present in population databases (rs80356750, gnomAD 0.009%). This sequence change creates a premature translational stop signal (p.Arg63*) in the ATP6V0A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATP6V0A2 are known to be pathogenic (PMID: 18157129, 19321599). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004579513 | SCV005062064 | pathogenic | Cutis laxa | 2024-03-18 | criteria provided, single submitter | clinical testing | Variant summary: ATP6V0A2 c.187C>T (p.Arg63X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 1.6e-05 in 250700 control chromosomes (gnomAD). c.187C>T has been reported in the literature in individuals affected with Cutis Laxa - ATP6V0A2 Related (example: Fischer_2012). These data indicate that the variant is likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 22773132). ClinVar contains an entry for this variant (Variation ID: 845). Based on the evidence outlined above, the variant was classified as pathogenic. |
Fulgent Genetics, |
RCV005007801 | SCV005634175 | pathogenic | Cutis laxa with osteodystrophy; Wrinkly skin syndrome | 2024-03-19 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000000888 | SCV000021038 | pathogenic | Cutis laxa with osteodystrophy | 2008-01-01 | no assertion criteria provided | literature only | |
Gene |
RCV000000888 | SCV000041230 | not provided | Cutis laxa with osteodystrophy | no assertion provided | literature only |